Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Fernández-Medarde

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Genes & Cancer|July 23, 2011
Ras in cancer and developmental diseasesAlberto Fernández-Medarde, Eugenio Santos
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Ras GEF Mouse Models for the Analysis of Ras Biology and SignalingAlberto Fernández-Medarde, Eugenio Santos
Biochimica Et Biophysica Acta|November 30, 2010
The RasGrf family of mammalian guanine nucleotide exchange factorsAlberto Fernández-Medarde, Eugenio Santos
Acta Pharmaceutica Sinica. B|September 15, 2021
The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriersEdgar Pérez-Herrero, Alberto Fernández-Medarde
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 28, 2015
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapyEdgar Pérez-Herrero, Alberto Fernández-Medarde
Methods and Protocols|February 24, 2023
Optimized Protocol for Isolation and Culture of Murine Neonatal Primary Lung FibroblastsRocío Fuentes-Mateos, Eugenio Santos, Alberto Fernández-Medarde
Acta Pharmaceutica Sinica. B|April 27, 2026
Albumin-based nanocarriers: Singularities, synthesis methods, clinical relevance and targeting strategies in cancerEdgar Pérez-Herrero, Alberto Fernández-Medarde, Juan M Irache
Genes|June 2, 2021
40 Years of RAS-A Historic OverviewAlberto Fernández-Medarde, Javier De Las Rivas, Eugenio Santos
Oncogene|April 13, 2004
C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growthCarmen Guerrero, Susana Martín-Encabo, Alberto Fernández-Medarde, et al.
Cell Death & Disease|November 6, 2019
Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in miceRocío Fuentes-Mateos, David Jimeno, Carmela Gómez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Genes & Cancer|July 23, 2011
Ras in cancer and developmental diseasesAlberto Fernández-Medarde, Eugenio Santos
Methods in Molecular Biology (Clifton, N.J.)|May 12, 2021
Ras GEF Mouse Models for the Analysis of Ras Biology and SignalingAlberto Fernández-Medarde, Eugenio Santos
Biochimica Et Biophysica Acta|November 30, 2010
The RasGrf family of mammalian guanine nucleotide exchange factorsAlberto Fernández-Medarde, Eugenio Santos
Acta Pharmaceutica Sinica. B|September 15, 2021
The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriersEdgar Pérez-Herrero, Alberto Fernández-Medarde
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 28, 2015
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapyEdgar Pérez-Herrero, Alberto Fernández-Medarde
Methods and Protocols|February 24, 2023
Optimized Protocol for Isolation and Culture of Murine Neonatal Primary Lung FibroblastsRocío Fuentes-Mateos, Eugenio Santos, Alberto Fernández-Medarde
Acta Pharmaceutica Sinica. B|April 27, 2026
Albumin-based nanocarriers: Singularities, synthesis methods, clinical relevance and targeting strategies in cancerEdgar Pérez-Herrero, Alberto Fernández-Medarde, Juan M Irache
Genes|June 2, 2021
40 Years of RAS-A Historic OverviewAlberto Fernández-Medarde, Javier De Las Rivas, Eugenio Santos
Oncogene|April 13, 2004
C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growthCarmen Guerrero, Susana Martín-Encabo, Alberto Fernández-Medarde, et al.
Cell Death & Disease|November 6, 2019
Concomitant deletion of HRAS and NRAS leads to pulmonary immaturity, respiratory failure and neonatal death in miceRocío Fuentes-Mateos, David Jimeno, Carmela Gómez, et al.
Pageof 3